Please try another search
For the three months ended 31 March 2022, N0 25 Central Pharmaceutical JSC revenues increased less than 1% to VND48.63B. Net income totaled VND124.2M vs. loss of VND359.3M. Revenues reflect market conditions. Net income reflects Other Non-Operating Income increase from VND0K to VND63.5M (income), Financial Income increase from VND38.9M to VND80.4M (income), Interest Expense decrease of 10% to VND62M (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 48630.92 | 44672.5 | 29411.93 | 43594.67 |
Gross Profit | 9053.81 | 5901.46 | 3179.58 | 4208.45 |
Operating Income | 69.97 | -1203 | -3144.05 | -2311 |
Net Income | 124.23 | -1203.06 | -3144.05 | -2533.34 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 380332.41 | 373054.85 | 373672.95 | 384632.06 |
Total Liabilities | 232417.74 | 225264.41 | 224679.44 | 232494.5 |
Total Equity | 147914.67 | 147790.44 | 148993.5 | 152137.56 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -10514.32 | 4851.05 | -7223.09 | -14537.45 |
Cash From Investing Activities | -1751.38 | 12962.03 | 11803.25 | 6800.22 |
Cash From Financing Activities | 4888.96 | -7913.21 | -7913.21 | 2509.53 |
Net Change in Cash | -7373.68 | 9923.2 | -3332.77 | -5226.8 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review